Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/23/1992 | EP0519728A2 Anti-TCF-II monoclonal antibodies and method for the measurement of TCF-II by applying the antibodies |
12/23/1992 | EP0519596A1 A method for reducing the immunogenicity of antibody variable domains |
12/23/1992 | EP0519547A2 Coccidiosis poultry vaccine |
12/23/1992 | EP0519336A2 Chimeric gene comprising a promoter-regulater and a gene coding for an indicator protein |
12/23/1992 | EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt |
12/23/1992 | EP0519011A1 Protein expression via seed specific regulatory sequences |
12/23/1992 | EP0518933A1 Leukaemia inhibitory factor |
12/23/1992 | EP0518920A1 Cell culture products. |
12/23/1992 | CA2111347A1 Method for inducing human myocardial cell proliferation |
12/23/1992 | CA2110387A1 Intercellular adhesion molecule-3 and its binding ligands |
12/23/1992 | CA2089653A1 Media concentrate technology |
12/22/1992 | US5173423 Process for breeding a glabrous variety of rice crop and a glabrous plant |
12/22/1992 | US5173421 For high density cell culture |
12/22/1992 | US5173420 Monoclonal antibody recognizing un-natural ganglioside gd3 |
12/22/1992 | US5173414 Production of recombinant adeno-associated virus vectors |
12/22/1992 | US5173399 Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests |
12/22/1992 | US5173294 Purified antiserum which recognizes homophilus influenzae outer membrane protein for treating diseases caused by pathogen |
12/22/1992 | CA2071622A1 Anti-tcf-ii monoclonal antibodies and method for the measurement of tcf-ii by applying the antibodies |
12/22/1992 | CA1311660C High speed automated injection system for avian embryos |
12/19/1992 | CA2071395A1 Coccidiosis poultry vaccine |
12/19/1992 | CA2071305A1 Anti-hiv antibodies |
12/19/1992 | CA2065919A1 Leydig cell stimulator |
12/18/1992 | WO1992022201A1 Process for producing magnetically responsive polymer particles and application thereof |
12/16/1992 | EP0518757A1 Peptides or polypeptides of BVD and related viruses |
12/16/1992 | EP0518756A1 Procedure to detect a bovine viral diarrhoea virus infection, nucleotide sequence coding for a protein induced by infection with this virus and recombinant proteins and antigens resulting from same |
12/16/1992 | EP0518583A1 Nucleotide sequences |
12/16/1992 | EP0518277A2 Method for separating and culturing fused hybrid cells |
12/16/1992 | EP0517918A1 Monoclonal antibody against cardiac glycoside and utilization thereof |
12/16/1992 | EP0517909A1 Modified hepatocytes and uses therefor |
12/16/1992 | EP0517815A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE |
12/16/1992 | EP0517779A1 SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-$g(b)1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN |
12/16/1992 | EP0517768A1 Mammalian expression vectors |
12/16/1992 | CN1019507B Culturing method and culture apparatus |
12/15/1992 | US5171844 For use in treating hemophilia |
12/15/1992 | US5171840 Receptor protein for human B cell stimulatory factor-2 |
12/15/1992 | US5171670 Recombinant dna method for production of parathyroid hormone |
12/15/1992 | US5171667 Radiolabeled monoclonal antibodies; diagnosis of cancer |
12/15/1992 | US5171666 Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas |
12/15/1992 | US5171665 Monoclonal antibody to novel antigen associated with human tumors |
12/15/1992 | US5171271 Prosthetics |
12/14/1992 | CA2071105A1 Nucleotide sequences |
12/12/1992 | WO1992022654A1 Vaccine and treatment method of human immunodeficiency virus infection |
12/12/1992 | CA2087732A1 Vaccine and treatment method of human immunodeficiency virus infection |
12/12/1992 | CA2071015A1 Immunogenic peptides or polypeptides of the bvd virus and related viruses, vaccines incorporating them or expressing them, methods and means of production thereof |
12/10/1992 | WO1992021766A1 Monoclonal antibodies against c-kit |
12/10/1992 | WO1992021763A1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences |
12/10/1992 | WO1992021762A1 A mouse immunoglobulin heavy-chain locus enhancer which crosshybridizes with the 3'-enhancer element of rat |
12/10/1992 | WO1992021756A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/10/1992 | WO1992021754A1 Dna which codes for secretin receptor and polypeptide which is coded for by said dna |
12/10/1992 | WO1992021753A1 Insecticidal proteins and method for plant protection |
12/10/1992 | WO1992021402A1 Method for improving autologous transplantation |
12/10/1992 | WO1992021371A1 Method of immortalizing human b-cells |
12/10/1992 | WO1992021240A1 Suppressor t-cell hybridoma |
12/10/1992 | WO1992021234A1 Composition and method for culturing and freezing cells and tissues |
12/10/1992 | WO1992014818A3 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
12/10/1992 | WO1992013078A3 Pasteurella haemolytica glycoprotease gene and the purified enzyme |
12/10/1992 | WO1992009690A3 Enrichment method for variant proteins with altered binding properties |
12/10/1992 | DE4118770A1 Preparing antibodies against unstable antigens, esp. active anaphylatoxin - by direct contact of immunogen and spleen cells, useful diagnostically and for treating elevated complement activation |
12/10/1992 | CA2109819A1 Insecticidal proteins and method for plant protection |
12/10/1992 | CA2109699A1 Method for improving autologous transplantation |
12/10/1992 | CA2103365A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/10/1992 | CA2103046A1 Suppressor t-cell hybridoma |
12/09/1992 | EP0517292A1 Recombinant Avipox virus |
12/09/1992 | EP0517199A1 Durable engraftment of human tissue and cells in normal mammals |
12/09/1992 | EP0516958A2 Caffeoyl-coA-3-O-methyltransferase gene |
12/09/1992 | EP0516863A1 ANTIBODY AGAINST HUMAN PLASMIN-$g(a) 2?-PLASMIN INHIBITOR COMPLEX, HYBRIDOMA AND IMMUNOASSAY |
12/09/1992 | EP0516845A1 Novel megakaryocytic colony stimulating factor and process for its preparation |
12/09/1992 | EP0516787A1 Expression systems |
12/09/1992 | EP0516664A1 Transgenic animals, cells and cell lines therefrom, and their use |
12/09/1992 | CN1019355B Process for minactivin and its use |
12/08/1992 | US5169835 Pregancy specific proteins applications |
12/08/1992 | US5169776 Method to obtain intact, viable protoplasts from pollen grains |
12/08/1992 | US5169773 Antibodies able to distinquish between cyclosporins and their metabolites; monotoring dosages; immunoassay; hybrid cells; kits |
12/08/1992 | US5169765 Method for stimulating production of bone marrow cell growth factors using dithiocarbamates |
12/08/1992 | US5169761 Dna encoding and expression systems for alveolar surfactant proteins |
12/08/1992 | US5169753 Reacting human serum with fractionated proteins from retrovirus, then assaying for serum antibody binding to selected retroviral proteins |
12/08/1992 | US5169720 Hydrated polymer gel derived from modified prepolymer of ethylene glycol or high molecular weight polyethers; biocompatible, transparent, hydrophilic, resistance to protein binding |
12/08/1992 | CA1311192C Tumor specific assay for ca125 ovarian cancer antigen |
12/07/1992 | WO1992021759A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof |
12/07/1992 | CA2088666A1 Nucleotide and peptide sequences of hepatitis c virus isolate, diagnostic and therapeutic applications |
12/04/1992 | WO1992021979A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/04/1992 | CA2103142A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/02/1992 | EP0516443A1 Vectors and methods for assaying the regulation of apolipoprotein ai synthesis |
12/02/1992 | EP0515569A1 Calcium channel compositions and methods |
12/02/1992 | EP0515536A1 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
12/02/1992 | EP0450048A4 Stable mammalian cell lines that express aromatase |
12/01/1992 | US5168064 Endo-1,4-β-glucanase gene and its use in plants |
12/01/1992 | US5168063 Strong binding of outer membrane protein; medical diagnosis |
12/01/1992 | US5168058 Packing material for anchorage-dependent cells |
12/01/1992 | US5168050 DNA constructs, mammalian expression vectors and host cells containing same |
12/01/1992 | US5168049 Production of streptavidin-like polypeptides |
12/01/1992 | US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e |
12/01/1992 | CA2070058A1 Vectors and methods for assaying the regulation of apolipoprotein ai synthesis |
12/01/1992 | CA2067317A1 Caffeoyl-coa 3-o-methyltransferase genes |
12/01/1992 | CA1310928C Herbicide-resistant crop plants, process for their selection and theirregeneration |
12/01/1992 | CA1310926C Process for replicating bone marrow and other tissues in vitro and using the same |
12/01/1992 | CA1310924C Infective drug delivery system |
11/28/1992 | CA2069594A1 Recombinant avipox virus, culture of cells infected by this virus and fowl vaccines derived therefrom |
11/26/1992 | WO1992021029A1 Selecting ligand agonists and antagonists |
11/26/1992 | WO1992020809A1 Method of creating a transformed rice plant |